First Time Loading...

SNDL Inc
F:VY4

Watchlist Manager
SNDL Inc Logo
SNDL Inc
F:VY4
Watchlist
Price: 1.847 EUR -2.53% Market Closed
Updated: Jun 17, 2024
Have any thoughts about
SNDL Inc?
Write Note

P/E
Price to Earnings

-5.1
Current
-4.6
Median
22.1
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-5.1
=
Market Cap
486.1m
/
Net Income
-139.6m
All Countries
Close
Market Cap P/E
CA
SNDL Inc
F:VY4
486.1m EUR -5.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY -5 347 888.9
US
Eli Lilly and Co
NYSE:LLY
834.9B USD 136
DK
Novo Nordisk A/S
CSE:NOVO B
4.4T DKK 49.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP -15 783.5
US
Johnson & Johnson
NYSE:JNJ
350.3B USD 9.1
US
Merck & Co Inc
NYSE:MRK
327.9B USD 142.2
UK
AstraZeneca PLC
LSE:AZN
193.9B GBP 38.8
CH
Roche Holding AG
SIX:ROG
197.4B CHF 17.2
CH
Novartis AG
SIX:NOVN
185.9B CHF 11.9
US
Pfizer Inc
NYSE:PFE
156B USD -504.9
Earnings Growth
CA
SNDL Inc
F:VY4
Average P/E: 57.8
Negative Multiple: -5.1
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
136
365%
DK
Novo Nordisk A/S
CSE:NOVO B
49.5
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9.1
-21%
US
Merck & Co Inc
NYSE:MRK
142.2
7 578%
UK
AstraZeneca PLC
LSE:AZN
38.8
172%
CH
Roche Holding AG
SIX:ROG
17.2
28%
CH
Novartis AG
SIX:NOVN
11.9
17%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -504.9
683%

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
38.1
2-Years Forward
P/E
266.4
3-Years Forward
P/E
N/A

See Also

Discover More